About BioSense Webster
BioSense Webster is a Healthcare company based in Diamond Bar (United States) founded in 1970 by Will Webster, and was acquired by Johnson & Johnson in September 1997. It operates as a solutions to treat Cardiac Arrythmia. BioSense Webster has completed 1 acquisition, including Coherex. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Biosense Webster, a part of Johnson and Johnson, is established in North America, Europe, Middle East and Africa. The specialties offered by the company include Atrial Fibrillation, Electrophysiology, Heart Rhythm Disorders, Catheter Ablation. The range of products are used for treating cardiac arrhythmias and it includes the CARTO System Solutions consisting of the complete 3-D Mapping System, Software, Catheters (therapeutic, diagnostic ultrasound), and Generators, Accessories, and Cables; and the Non-Navigational Products consist of catheters, access, and cables. The company also offers solutions for physicians, especially the Electrophysiologists and the cardiologists.
- Headquarters Diamond Bar, United States
- Founders Will Webster
- Stage Acquired
- SectorsHealthcare
- Website biosensewebster.com
- Social LinkedIn X
- Acquired by Johnson & Johnson (Sep 1997)
- Investors
- Investments & Acquisitions
- Acquired byJohnson & Johnson
(Sep 1997)
Investors in BioSense Webster
BioSense Webster has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | jnj.com | New Brunswick, United States |
Investor details for BioSense Webster
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioSense Webster
1 people are tracked at BioSense Webster (1 in leadership).
| Name | Role | Group |
|---|---|---|
Will Webster | Founder | Leadership |
Complete people profiles for BioSense Webster
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioSense Webster
BioSense Webster has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Coherex.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Structural heart disease conditions are addressed with implant devices. | coherex.com | Salt Lake, United States | 2003 | Nov 2015 | •••• |
Complete acquisition details for BioSense Webster
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioSense Webster
3 dated milestones of BioSense Webster across 45 years, from founding to its latest funding, stage changes and deals.
- Founded BioSense Webster is founded.
- Exit Acquired by Johnson & Johnson.
- Acquisition Acquires Coherex.
Competitors of BioSense Webster
BioSense Webster has 10 listed competitors in our database, 8 of them funded. They include AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| atricure.com | 2000 | Mason, United States | – | 1,874 | Cardiac ablation and occlusion devices for atrial fibrillation are provided. | |
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. | |
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. | |
| tyrx.com | 1998 | Monmouth Junction, United States | $80.67M | 42 | Antibacterial envelopes are developed for stabilizing cardiac implantable devices. | |
| apamamedical.com | 2009 | Campbell, United States | $28.47M | 45 | Catheter ablation technology for atrial fibrillation treatment is developed. | |
| eba-med.com | 2018 | Geneva, Switzerland | $18.64M | – | Non-invasive treatments for cardiac arrhythmias are developed by EBAMed. | |
| ebrsystemsinc.com | 2003 | Sunnyvale, United States | $179.73M | – | Wireless cardiac pacing devices are developed for left ventricle stimulation. | |
| cathvision.com | 2013 | Copenhagen, Denmark | $36.08M | 21 | Provider and developer of an AI-based cardiac ablation therapy software and device | |
| biosensewebsterlogin.com | 1970 | Irvine, United States | – | – | Mapping catheters for cardiac arrhythmia treatment are developed. |
Detailed competitors of BioSense Webster
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioSense Webster
The website of BioSense Webster (biosensewebster.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 28.2% vs previous month
Websites whose visitors overlap most with BioSense Webster. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
orthoclinical.com | orthoclinical.com | 100% | – | #4,625,249 | – |
| medtronic.com | 97% | 2.6M | #22,622 | View details | |
| sjm.com | 92% | 1.2K | #13,629,967 | View details | |
| bostonscientific.com | 89% | 738.5K | #88,615 | View details | |
| onetouch.com | 74% | 121K | #302,906 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for BioSense Webster
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as BioSense Webster (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biosense Webster
Complete news archive for BioSense Webster
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioSense Webster
BioSense Webster was founded in 1970.
BioSense Webster is headquartered in Diamond Bar, United States. It is registered at Diamond Bar, California, United States.
Biosense Webster, a part of Johnson and Johnson, is established in North America, Europe, Middle East and Africa. The specialties offered by the company include Atrial Fibrillation, Electrophysiology, Heart Rhythm Disorders, Catheter Ablation. The range of products are used for treating cardiac arrhythmias and it includes the CARTO System Solutions consisting of the complete 3-D Mapping System, Software, Catheters (therapeutic, diagnostic ultrasound), and Generators, Accessories, and Cables; and the Non-Navigational Products consist of catheters, access, and cables. The company also offers solutions for physicians, especially the Electrophysiologists and the cardiologists.
BioSense Webster's top competitors include AtaCor Medical, AtriCure and CardioFocus.
BioSense Webster has made 1 acquisition, including Coherex.
BioSense Webster has 1 investor. Key investors include Johnson & Johnson.
Yes. BioSense Webster was acquired by Johnson & Johnson in September 1997.